BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 25413431)

  • 1. Patterns of care and brachytherapy boost utilization for vaginal cancer in the United States.
    Rajagopalan MS; Xu KM; Lin J; Hansen K; Sukumvanich P; Krivak TC; Kelley JL; Beriwal S
    Pract Radiat Oncol; 2015; 5(1):56-61. PubMed ID: 25413431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. National Cancer Data Base analysis of radiation therapy consolidation modality for cervical cancer: the impact of new technological advancements.
    Gill BS; Lin JF; Krivak TC; Sukumvanich P; Laskey RA; Ross MS; Lesnock JL; Beriwal S
    Int J Radiat Oncol Biol Phys; 2014 Dec; 90(5):1083-90. PubMed ID: 25216857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adoption and impact of concurrent chemoradiation therapy for vaginal cancer: a National Cancer Data Base (NCDB) study.
    Rajagopalan MS; Xu KM; Lin JF; Sukumvanich P; Krivak TC; Beriwal S
    Gynecol Oncol; 2014 Dec; 135(3):495-502. PubMed ID: 25281493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-dose-rate interstitial brachytherapy for gynecologic malignancies.
    Beriwal S; Bhatnagar A; Heron DE; Selvaraj R; Mogus R; Kim H; Gerszten K; Kelley J; Edwards RP
    Brachytherapy; 2006; 5(4):218-22. PubMed ID: 17118313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trends in the utilization of brachytherapy in cervical cancer in the United States.
    Han K; Milosevic M; Fyles A; Pintilie M; Viswanathan AN
    Int J Radiat Oncol Biol Phys; 2013 Sep; 87(1):111-9. PubMed ID: 23849695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patterns of care and impact of brachytherapy boost utilization for squamous cell carcinoma of the base of tongue in a large, national cohort.
    Lee A; Givi B; Wu SP; Tam MM; Gerber NK; Hu KS; Han P; Schreiber D
    Brachytherapy; 2017; 16(6):1205-1212. PubMed ID: 28943128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patterns of brachytherapy practice for patients with carcinoma of the cervix (1996-1999): a patterns of care study.
    Erickson B; Eifel P; Moughan J; Rownd J; Iarocci T; Owen J
    Int J Radiat Oncol Biol Phys; 2005 Nov; 63(4):1083-92. PubMed ID: 16099599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brachytherapy improves survival in primary vaginal cancer.
    Orton A; Boothe D; Williams N; Buchmiller T; Huang YJ; Suneja G; Poppe M; Gaffney D
    Gynecol Oncol; 2016 Jun; 141(3):501-506. PubMed ID: 27036631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. American Brachytherapy Society survey regarding practice patterns of postoperative irradiation for endometrial cancer: current status of vaginal brachytherapy.
    Small W; Erickson B; Kwakwa F
    Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1502-7. PubMed ID: 16109462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute genitourinary toxicity after high-dose-rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity.
    Akimoto T; Ito K; Saitoh J; Noda SE; Harashima K; Sakurai H; Nakayama Y; Yamamoto T; Suzuki K; Nakano T; Niibe H
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):463-71. PubMed ID: 16168838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The decreased use of brachytherapy boost for intermediate and high-risk prostate cancer despite evidence supporting its effectiveness.
    Orio PF; Nguyen PL; Buzurovic I; Cail DW; Chen YW
    Brachytherapy; 2016; 15(6):701-706. PubMed ID: 27317191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary radiotherapy for nonsurgically managed Stage I endometrial cancer: Utilization and impact of brachytherapy.
    Gill BS; Chapman BV; Hansen KJ; Sukumvanich P; Beriwal S
    Brachytherapy; 2015; 14(3):373-9. PubMed ID: 25600451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Definitive radiotherapy for primary vaginal cancer: correlation between treatment patterns and recurrence rate.
    Kanayama N; Isohashi F; Yoshioka Y; Baek S; Chatani M; Kotsuma T; Tanaka E; Yoshida K; Seo Y; Suzuki O; Mabuchi S; Shiki Y; Tatsumi K; Kimura T; Teshima T; Ogawa K
    J Radiat Res; 2015 Mar; 56(2):346-53. PubMed ID: 25614068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stereotactic Body Radiation Therapy, Intensity-Modulated Radiation Therapy, and Brachytherapy Boost Modalities in Invasive Cervical Cancer: A Study of the National Cancer Data Base.
    OʼDonnell B; Shiao JC; Pezzi TA; Waheed N; Sharma S; Bonnen MD; Ludwig MS
    Int J Gynecol Cancer; 2018 Mar; 28(3):563-574. PubMed ID: 29324547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direct 2-arm comparison shows benefit of high-dose-rate brachytherapy boost vs external beam radiation therapy alone for prostate cancer.
    Khor R; Duchesne G; Tai KH; Foroudi F; Chander S; Van Dyk S; Garth M; Williams S
    Int J Radiat Oncol Biol Phys; 2013 Mar; 85(3):679-85. PubMed ID: 22954770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary squamous cell carcinoma of the vagina: prognostic factors, treatment patterns, and outcomes.
    Hiniker SM; Roux A; Murphy JD; Harris JP; Tran PT; Kapp DS; Kidd EA
    Gynecol Oncol; 2013 Nov; 131(2):380-5. PubMed ID: 23954572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of brachytherapy in the boost management of anal carcinoma with node involvement (CORS-03 study).
    Moureau-Zabotto L; Ortholan C; Hannoun-Levi JM; Teissier E; Cowen D; Salem N; Lemanski C; Ellis S; Resbeut M
    Int J Radiat Oncol Biol Phys; 2013 Mar; 85(3):e135-42. PubMed ID: 23195780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conformal high dose rate iridium-192 boost brachytherapy in locally advanced prostate cancer: superior prostate-specific antigen response compared with external beam treatment.
    Stromberg JS; Martinez AA; Horwitz EM; Gustafson GS; Gonzalez JA; Spencer WF; Brabbins DS; Dmuchowski CF; Hollander JB; Vicini FA
    Cancer J Sci Am; 1997; 3(6):346-52. PubMed ID: 9403047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patterns of care and outcomes for women with uterine cancer and ovarian metastases.
    Jones NL; Huang Y; Chatterjee S; Tergas AI; Burke WM; Hou JY; Deutsch I; Ananth CV; Neugut AI; Hershman DL; Wright JD
    Int J Gynecol Cancer; 2019 Feb; 29(2):365-376. PubMed ID: 30718315
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of vaginal recurrences in endometrial carcinoma by high-dose-rate brachytherapy.
    Sorbe B; Söderström K
    Anticancer Res; 2013 Jan; 33(1):241-7. PubMed ID: 23267151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.